[Retracted] Expression of α‑fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.
1/5 보강
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that several instances of duplicated data existed within several of the figures in this article; s
APA
Lu S, Ma Y, et al. (2025). [Retracted] Expression of α‑fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.. Oncology reports, 54(3). https://doi.org/10.3892/or.2025.8945
MLA
Lu S, et al.. "[Retracted] Expression of α‑fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.." Oncology reports, vol. 54, no. 3, 2025.
PMID
40908679 ↗
Abstract 한글 요약
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that several instances of duplicated data existed within several of the figures in this article; specifically: i) two pairs of data panels in the four‑panel Fig. 2B (so affecting all the panels in this figure part, which showed the results from migration and invasion assay experiments) were overlapping; ii) a pair of data panels for the fluorescence experiments shown in Fig. 4 were also found to be overlapping; and iii) one set of protein bands in the western blots featured in Fig. 5 (for the caspase‑3 data) had also been included in a paper submitted to and published in a few months earlier, with the author Tao Sun held in common between these papers. Owing to the number of cases of data duplication that were identified in this paper, the Editor of has decided that it should be retracted from the Journal on account of a lack of confidence in the presented data. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 35: 2984‑2990, 2016; DOI: 10.3892/or.2016.4678].
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial.
- Treatment Patterns and Clinical Outcomes in Unresectable Stage III EGFR-Mutated Non-Small Cell Lung Cancer in China.
- Orbicularis Oculi Toxin Injection for Treating Levator Palpebrae Superioris Weakness: Clinical Effect and Safety in a Cohort Study.
- A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
- Complete Remission in BCLC Stage C Hepatocellular Carcinoma Treated with HAIC Combined with PD-1 Inhibitors and Anti-angiogenic Therapy.
📖 전문 본문 읽기 PMC JATS · ~2 KB · 영문
Oncol Rep 35: 2984–2990, 2016; DOI: 10.3892/or.2016.4678
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that several instances of duplicated data existed within several of the figures in this article; specifically:
i) two pairs of data panels in the four-panel Fig. 2B (so affecting all the panels in this figure part, which showed the results from migration and invasion assay experiments) were overlapping;
ii) a pair of data panels for the fluorescence experiments shown in Fig. 4 were also found to be overlapping;
and iii) one set of protein bands in the western blots featured in Fig. 5 (for the caspase-3 data) had also been included in a paper submitted to and published in Oncology Reports a few months earlier, with the author Tao Sun held in common between these papers.
Owing to the number of cases of data duplication that were identified in this paper, the Editor of Oncology Reports has decided that it should be retracted from the Journal on account of a lack of confidence in the presented data. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that several instances of duplicated data existed within several of the figures in this article; specifically:
i) two pairs of data panels in the four-panel Fig. 2B (so affecting all the panels in this figure part, which showed the results from migration and invasion assay experiments) were overlapping;
ii) a pair of data panels for the fluorescence experiments shown in Fig. 4 were also found to be overlapping;
and iii) one set of protein bands in the western blots featured in Fig. 5 (for the caspase-3 data) had also been included in a paper submitted to and published in Oncology Reports a few months earlier, with the author Tao Sun held in common between these papers.
Owing to the number of cases of data duplication that were identified in this paper, the Editor of Oncology Reports has decided that it should be retracted from the Journal on account of a lack of confidence in the presented data. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.
출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Treating a single tumor deposits as two lymph node metastases can improve the accuracy of gastric cancer prognosis assessment.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.